Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Recruiting 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2Gynecologic 1Breast 1

Conditions

Lung Neoplasms 3Breast Neoplasms 3Hematopoietic and Lymphatic System Neoplasm 2Colorectal Neoplasms 2Uterine Cervical Neoplasms 1Neoplastic Syndromes, Hereditary 1Malignant Solid Neoplasm 1Cigarette Smoking-Related Carcinoma 1

Interventions

Bevacizumab 77Fluorouracil 55Cetuximab 48Oxaliplatin 43Leucovorin 42pembrolizumab 37Irinotecan 33Folfox protocol 24Capecitabine 24HMPL-013 22Specimen Handling 19trifluridine tipiracil drug combination 17Panitumumab 15Blood Specimen Collection 15Nivolumab 14Magnetic Resonance Spectroscopy 14regorafenib 13Biopsy 13Trifluridine 12Gemcitabine 12Cisplatin 12Standard of Care 11sintilimab 10Interviews as Topic 10IFL protocol 10Drug Therapy 10Carboplatin 10Cyclophosphamide 9tislelizumab 8Trastuzumab 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × Colorectal Neoplasms × Health Promotion × Clear all
NCT07229443 2026-05-12

CoGENES Randomized Controlled Trial (RCT)

University of Southern California

Phase NA Recruiting
140 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT06666192 2025-12-24

The Ohio State University (OSU) SCREEN Community Program

Ohio State University Comprehensive Cancer Center

Phase NA Recruiting
2,067 enrolled
BreastGastrointestinalGynecologic

Breast Neoplasms, Uterine Cervical Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡